EE404 A Cost-Effectiveness Analysis of a Triple-Agent Topical Fixed-Dose Combination of 1.2% Clindamycin Phosphate, 0.15% Adapalene, and 3.1% Benzoyl Peroxide Gel for the Treatment of Moderate-to-Severe Acne Vulgaris in the United States

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Value in Health

Topics

Chemistry

Biochemistry

Medicine

Dermatology

Organic Chemistry

Show all topics

DOI

10.1016/j.jval.2024.03.700